Study of chronic toxicity of the GB-115 drug formulation
The results of the study of chronic toxicity of the drug formulation of anxiolytic GB-115 are presented. The novel dipeptide in the form of a tablet mass was administered daily orally for 6 months to outbred rats and rabbits of the chinchilla breed at a dose of 1 mg/kg corresponding to the therapeut...
Main Authors: | A. V. Sorokina, S. V. Alekseeva, I. A. Miroshkina, V. V. Zabrodina, L. G. Kolik, A. D. Durnev |
---|---|
Formato: | Artigo |
Idioma: | Russian |
Publicado em: |
LLC “Publisher OKI”
2020-04-01
|
Colecção: | Фармакокинетика и Фармакодинамика |
Assuntos: | |
Acesso em linha: | https://www.pharmacokinetica.ru/jour/article/view/230 |
Registos relacionados
-
Experimental assessment of ladasten and GB-115 effects on the antinociceptive tolerance to morphine
Por: M. A. Konstantinopolsky, et al.
Publicado em: (2016-03-01) -
Pharmacokinetics of dipeptide anxiolytic GB-115 after oral administration in different animals species and humans
Por: S. Yu. Raskin, et al.
Publicado em: (2017-07-01) -
Clinical pharmacokinetics of а new original dipeptide anxiolytic GB-115
Por: V. P. Zherdev, et al.
Publicado em: (2017-02-01) -
Study the subchronic toxicity of the drug Dantinorm Baby
Por: A. V. Sorokina, et al.
Publicado em: (2021-06-01) -
Study of acute and chronic toxicity of homeopathic syrup Stodal
Por: S. V. Alekseeva, et al.
Publicado em: (2020-07-01)